Response of circulating somatostatin, insulin, gastrin and GIP, to intraduodenal infusion of nutrients in normal man
- PMID: 6148162
- DOI: 10.1111/j.1365-2265.1984.tb03461.x
Response of circulating somatostatin, insulin, gastrin and GIP, to intraduodenal infusion of nutrients in normal man
Abstract
We have studied the effect of direct infusion of nutrients into the duodenum of normal subjects on circulating plasma somatostatin, insulin, gastrin and gastric inhibitory polypeptide (GIP) levels. Six normal subjects were given on four separate occasions 150 ml of isotonic solutions containing 100 calories of carbohydrate, protein, or fat, and a control solution of saline, by infusion into the second part of the duodenum. Plasma somatostatin rose slightly after carbohydrate, mean basal 30 +/- 3 pg/ml, peak 46 +/- 16 pg/ml at 15 min; and more markedly after protein, peak 57 +/- 9 pg/ml at 30 min. However, fat was the most potent intraduodenal stimulus to plasma somatostatin release into circulation, peak 101 +/- 11 pg/ml at 30 min. The plasma insulin rise was greatest after carbohydrate, peak 68 +/- 10 i.u., but there was a significant rise after protein also, peak 34 +/- 6 i.u. Plasma gastrin rose significantly after protein only, peak 70 +/- 22 pg/ml. Plasma GIP rose markedly after carbohydrate, basal 506 +/- 50 pg/ml, peak 1480 +/- 120 pg/ml. Protein was also a potent stimulus of circulating plasma GIP release, peak 1200 +/- 190 pg/ml, while fat was the least potent, peak 730 +/- 190 pg/ml. Thus, calorie for calorie, fat is the most potent intraduodenal nutrient stimulus of circulating somatostatin. We postulate therefore that somatostatin may be an enterogastrone--a circulating hormone released by intraduodenal fat which inhibits gastric acid secretion. Fat is the least potent intraduodenal nutrient stimulus of circulating GIP release. This is evidence against the hypothesis that circulating GIP acts as an enterogastrone.
Similar articles
-
Inhibition of gastric secretion by fat and hypertonic glucose in the dog: role of gastric inhibitory peptide.J Physiol. 1983 Jan;334:91-101. doi: 10.1113/jphysiol.1983.sp014482. J Physiol. 1983. PMID: 6864570 Free PMC article.
-
Correlation of endogenous somatostatin, gastric inhibitory polypeptide, glucagon and insulin with gastric function in the conscious calf.J Endocrinol. 1981 Jun;89(3):451-6. doi: 10.1677/joe.0.0890451. J Endocrinol. 1981. PMID: 6114125
-
Preceding hyperinsulinemia prevents demonstration of insulin effect on fat-induced gastric inhibitory polypeptide (GIP).Diabetes. 1984 Jun;33(6):580-5. doi: 10.2337/diab.33.6.580. Diabetes. 1984. PMID: 6373462
-
Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.J Physiol Pharmacol. 1994 Dec;45(4 Suppl 1):3-66. J Physiol Pharmacol. 1994. PMID: 7787215 Review.
-
Physiological role of somatostatin in the digestive tract: gastric acid secretion, intestinal absorption, and motility.Scand J Gastroenterol Suppl. 1986;119:47-53. doi: 10.3109/00365528609087431. Scand J Gastroenterol Suppl. 1986. PMID: 2876506 Review.
Cited by
-
Glucose-dependent insulinotropic polypeptide (GIP).Mol Metab. 2025 May;95:102118. doi: 10.1016/j.molmet.2025.102118. Epub 2025 Feb 28. Mol Metab. 2025. PMID: 40024571 Free PMC article. Review.
-
Autonomic regulation of postprandial plasma somatostatin, gastrin, and insulin.Gut. 1985 Jul;26(7):683-8. doi: 10.1136/gut.26.7.683. Gut. 1985. PMID: 2862095 Free PMC article.
-
Effect of secretin and somatostatin on secretion of epidermal growth factor from Brunner's glands in the rat.Dig Dis Sci. 1994 Oct;39(10):2186-90. doi: 10.1007/BF02090369. Dig Dis Sci. 1994. PMID: 7924740
-
A physiologic role for somatostatin 28 as a regulator of insulin secretion.J Clin Invest. 1989 Sep;84(3):857-62. doi: 10.1172/JCI114246. J Clin Invest. 1989. PMID: 2569481 Free PMC article.
-
Effects of oleic acid and endogenous bile on duodenal secretion of somatostatin in man.Dig Dis Sci. 1992 Jul;37(7):1025-8. doi: 10.1007/BF01300282. Dig Dis Sci. 1992. PMID: 1352199
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical